Deltex Medical Group (LSE:DEMG) Growth Rank : 0 (As of Jun. 02, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group Growth Rank?

Deltex Medical Group has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Deltex Medical Group Growth Rank Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltex Medical Group (LSE:DEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

DTXMF:USA

Address

Terminus Road, Chichester, W Sussex, GBR, PO19 8TX

Website

https://www.deltexmedical.com/

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines